The FDA's Center for Devices and Radiological Health recently held a workshop on women-specific issues in clinical trials of cardiovascular products. Workshop participants discussed possible policies regarding investigating sex differences in these studies. "The knowledge gap will never be closed if the pre-market investigation paradigm is not changed," said an FDA official.

Related Summaries